Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-06-26

Clinical Trial Update: An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

View source ↗

Summary

An observational study evaluating treatment compliance in children treated with growth hormone has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Status: WITHDRAWN